This content is machine translated Scar treatment Laser medical applications for different types of scars – an update. The success of scar treatment depends on various factors. There is still no universally valid gold standard. An approach based on individual circumstances has proven successful. Depending on the type…
View Post 4 min This content is machine translated Atopic dermatitis Dupilumab newly approved in Switzerland from 12 years of age Especially in adolescents, moderate to severe atopic dermatitis is associated with a high degree of suffering. In the pivotal study, dupilumab resulted in rapid and sustained relief of skin lesions…
View Post 4 min This content is machine translated Psoriatic Arthritis Another JAK inhibitor has cleared the approval hurdle In patients with psoriatic arthritis who do not respond adequately to conventional DMARDs or a biologic, the EULAR recommendations advise the use of a JAK inhibitor. Recently, upadacitinib, another member…
View Post 10 min This content is machine translated Aesthetic dermatology Filler and thread lifting The natural aging process of the face leads to a loss of volume caused by the resorption of subcutaneous tissue. Over the years, not only the superficial and deep fat… CME-Test
View Post 4 min This content is machine translated Chronic wounds Modern wound care – an update In the case of wound healing disorders, an interdisciplinary diagnosis is recommended. In addition to treatment of the underlying disease, local wound treatment is the most important pillar of therapy.…
View Post 4 min This content is machine translated Benign tumors in childhood Validated tool for triage in infantile hemangiomas. Infantile hemangioma is the most common benign tumor in childhood. If therapy is initiated in time, the treatment options are very good, otherwise it can have unpleasant late consequences for…
View Post 6 min This content is machine translated Dupilumab for the treatment of atopic dermatitis Reduction of Th2-mediated inflammation – therapeutic success also in adolescents Th2-mediated inflammatory processes play a central pathogenetic role in atopic dermatitis. This is the therapeutic target of the IL4/IL13 inhibitor dupilumab, which was recently approved in Switzerland also for adolescents…
View Post 3 min This content is machine translated Baricitinib First oral JAK inhibitor approved for the treatment of atopic dermatitis The use of small molecule drugs for the treatment of atopic dermatitis has been investigated for some time. With the approval of the Janus kinase (JAK) inhibitor baricitinib, a new…
View Post 2 min This content is machine translated Dermatoses in pandemic times: Therapy of the overreacting immune system Weighing the use of biologics – therapy can usually be carried out without hesitation Severe skin diseases are nowadays successfully treated with system-modulating or system-suppressive drugs. With the onset of the corona pandemic, dermatologists asked themselves how to proceed with the therapy of systemically…
View Post 4 min This content is machine translated Psoriasis infestation of scalp, nails and palmoplantar Excellent long-term data – IL23 inhibitor improves symptoms and quality of life Psoriasis in highly visible locations is particularly stigmatizing for patients. There is a high demand for effective and safe treatment options, especially for severe forms of the disease. Of those…
View Post 3 min This content is machine translated Advanced malignant melanoma Adjuvant immunotherapy with nivolumab: promising long-term results According to current study data, more than half of the patients who received adjuvant treatment with the anti-PD-1 antibody were relapse-free after four years. This is further confirmation of the…
